scholarly journals Buckling procedures for retinal detachment caused by retrolental fibroplasia in premature babies.

1980 ◽  
Vol 64 (2) ◽  
pp. 98-101 ◽  
Author(s):  
E Grunwald ◽  
Y Yassur ◽  
I Ben-Sira
Keyword(s):  
Retinal Detachment ◽  
Retrolental Fibroplasia ◽  
Premature Babies

Russian Roulette in the Nursery—Again

PEDIATRICS ◽  
1982 ◽  
Vol 69 (3) ◽  
pp. 380-381
Author(s):  
William A. Silverman
Keyword(s):  
Clinical Trial ◽  
Retinal Detachment ◽  
Active Treatment ◽  
Retinopathy Of Prematurity ◽  
Scleral Buckling ◽  
Prospective Clinical Trial ◽  
Retrolental Fibroplasia ◽  
The Past ◽  
Ultimate Fate

In 1980, a review appeared in the ophthalmology literature1 that summarized attempts at active treatment of the neovascular changes in retinopathy of prematurity (ROP) (referred to in the past as "proliferative retrolental fibroplasia [RLF]") and of retinal detachment which may occur in the disorder. The author of the survey observed (among a number of treatments tried) that the effectiveness of transscleral cryotherapy for treatment of proliferative changes was difficult to evaluate and he pointed out that "no prospective clinical trial has demonstrated the value [of this approach]." In respect to scleral buckling, as treatment for detachments in ROP, he remarked that although the approach seemed to be rational, the "ultimate fate of [treated] eyes remains uncertain."

FINE IN AN INFANT DRUG CASE

PEDIATRICS ◽  
1989 ◽  
Vol 84 (2) ◽  
pp. A29-A29
Author(s):  
Student
Keyword(s):  
Drug Application ◽  
Federal District ◽  
Vice President ◽  
District Court ◽  
Retrolental Fibroplasia ◽  
Infant Deaths ◽  
Work Release ◽  
Premature Babies ◽  
Release Program ◽  
New Drug Application

St. Louis, Jan. 21 (AP)—A pharmaceutical company has been fined $115,000 and a former executive sentenced to six months in a work-release program for marketing an unapproved drug linked to the death of 38 premature babies. The sentences were imposed Friday by Judge Clyde Cahill of Federal District Court here, which had jurisdiction in the case because the company, O'Neal, Jones & Feldman Pharmaceuticals, now called O'Neal Inc., is based in the St. Louis suburb of Maryland Heights. O'Neal was the sole distributor of E-Ferol Aqueous Solution, used for treatment of retrolental fibroplasia, a disease that can cause blindness in premature infants exposed to too much oxygen. The product, which was never tested by the Food and Drug Administration, was introduced in 1983 and recalled in 1984, after reports of infant deaths associated with its use. The executive who was sentenced Friday is James B. Madison, a 68-year-old former O'Neal vice president for operations, who had pleaded guilty to wire fraud and mislabeling. In addition to the six months in a work-release program, Judge Cahill sentenced him to three years' probation and ordered him to contribute $10,000 to a charity that helps children. O'Neal, which had pleaded guilty to charges including mail fraud and failure to obtain approval of a new drug application, was ordered to pay $125,000 in court costs in addition to the $115,000 fine. The sentences were handed down one day after Judge Cahill imposed a $130,000 fine on the drug's now-defunct manufacturer, Carter-Glogau Laboratories of Glendale, Ariz. Its former president, Ronald M. Carter, and O'Neal's former president, Larry K. Hiland, were sentenced to six months in prison by Judge Cahill, who ordered them to contribute $65,000 each toward research on drug safety. Carter-Glogau, Mr. Carter and Mr. Hiland had all been convicted of conspiracy, marketing and unapproved drug and misbranding the drug. The two companies and their insurers have reached settlements totaling millions of dollars with the families of children treated with the drug.

The Importance of Ophthalmoscopic Examinations in the Prophylaxis of Retrolental Fibroplasia in Premature Babies

2015 ◽  
pp. 280-281
Author(s):  
I. Norska ◽  
T. Niebroj ◽  
M. Piasecka ◽  
M. Dudkiewicz ◽  
A. Lukas
Keyword(s):  
Retrolental Fibroplasia ◽  
Premature Babies

Retinal Detachment in Retrolental Fibroplasia

1980 ◽  
Vol 181 (5) ◽  
pp. 261-265 ◽  
Author(s):  
M. Starzycka ◽  
A. Ciechanowska ◽  
A. Gergovich
Keyword(s):  
Retinal Detachment ◽  
Retrolental Fibroplasia

scholarly journals Morphological hallmarks in early stage retinopathy in premature babies (retrolental fibroplasia)

2019 ◽  
Vol 8 (2) ◽  
pp. 76
Author(s):  
Deyan Dzhenkov ◽  
George Stoyanov ◽  
Hristo Popov ◽  
Lyuben Stoev ◽  
Ina Kobakova ◽  
...  
Keyword(s):  
Early Stage ◽  
Retrolental Fibroplasia ◽  
Premature Babies

Retinal Detachment in Young Premature Infants with Acute Retrolental Fibroplasia

Ophthalmology ◽  
1982 ◽  
Vol 89 (10) ◽  
pp. 1160-1169 ◽  
Author(s):  
Alice R. McPherson ◽  
Helen Mintz Hittner ◽  
Ruben Lemos
Keyword(s):  
Retinal Detachment ◽  
Premature Infants ◽  
Retrolental Fibroplasia

Device Reduces Transfusions in Premature Babies

2006 ◽  
Vol 40 (7) ◽  
pp. 7
Author(s):  
JANE SALODOF MACNEIL
Keyword(s):  
Premature Babies
Sign in / Sign up

Export Citation Format

Share Document